305 related articles for article (PubMed ID: 8391380)
1. Synovial sarcoma of the abdominal wall.
Fetsch JF; Meis JM
Cancer; 1993 Jul; 72(2):469-77. PubMed ID: 8391380
[TBL] [Abstract][Full Text] [Related]
2. Synovial sarcoma involving the head: analysis of 36 cases with predilection to the parotid and temporal regions.
Al-Daraji W; Lasota J; Foss R; Miettinen M
Am J Surg Pathol; 2009 Oct; 33(10):1494-503. PubMed ID: 19623036
[TBL] [Abstract][Full Text] [Related]
3. Synovial sarcoma of the extremities: a clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial, and poorly differentiated areas.
Machen SK; Easley KA; Goldblum JR
Am J Surg Pathol; 1999 Mar; 23(3):268-75. PubMed ID: 10078916
[TBL] [Abstract][Full Text] [Related]
4. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases.
Makhlouf HR; Ahrens W; Agarwal B; Dow N; Marshalleck JJ; Lee EL; Dotto JE; Hui P; Sobin LH; Oliveira A; Miettinen M
Am J Surg Pathol; 2008 Feb; 32(2):275-81. PubMed ID: 18223331
[TBL] [Abstract][Full Text] [Related]
5. Minute synovial sarcomas of the hands and feet: a clinicopathologic study of 21 tumors less than 1 cm.
Michal M; Fanburg-Smith JC; Lasota J; Fetsch JF; Lichy J; Miettinen M
Am J Surg Pathol; 2006 Jun; 30(6):721-6. PubMed ID: 16723849
[TBL] [Abstract][Full Text] [Related]
6. Synovial sarcoma--identification of favorable and unfavorable histologic types: a Scandinavian sarcoma group study of 104 cases.
Skytting B; Meis-Kindblom JM; Larsson O; Virolainen M; Perfekt R; Akerman M; Kindblom LG
Acta Orthop Scand; 1999 Dec; 70(6):543-54. PubMed ID: 10665717
[TBL] [Abstract][Full Text] [Related]
7. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
[TBL] [Abstract][Full Text] [Related]
8. Synovial sarcoma: the importance of size and location for survival.
Deshmukh R; Mankin HJ; Singer S
Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147
[TBL] [Abstract][Full Text] [Related]
9. Synovial sarcoma. Inter-relationship of the biphasic and monophasic subtypes.
Dardick I; Ramjohn S; Thomas MJ; Jeans D; Hammar SP
Pathol Res Pract; 1991 Sep; 187(7):871-85. PubMed ID: 1661412
[TBL] [Abstract][Full Text] [Related]
10. Primary pulmonary sarcomas with features of monophasic synovial sarcoma: a clinicopathological, immunohistochemical, and ultrastructural study of 25 cases.
Zeren H; Moran CA; Suster S; Fishback NF; Koss MN
Hum Pathol; 1995 May; 26(5):474-80. PubMed ID: 7750931
[TBL] [Abstract][Full Text] [Related]
11. Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Virchows Arch; 2000 Sep; 437(3):275-83. PubMed ID: 11037348
[TBL] [Abstract][Full Text] [Related]
12. Intra-abdominal synovial sarcoma: a clinicopathological study.
Fisher C; Folpe AL; Hashimoto H; Weiss SW
Histopathology; 2004 Sep; 45(3):245-53. PubMed ID: 15330802
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in synovial sarcoma.
Rööser B; Willén H; Hugoson A; Rydholm A
Cancer; 1989 Jun; 63(11):2182-5. PubMed ID: 2541885
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients.
Trassard M; Le Doussal V; Hacène K; Terrier P; Ranchère D; Guillou L; Fiche M; Collin F; Vilain MO; Bertrand G; Jacquemier J; Sastre-Garau X; Bui NB; Bonichon F; Coindre JM
J Clin Oncol; 2001 Jan; 19(2):525-34. PubMed ID: 11208847
[TBL] [Abstract][Full Text] [Related]
15. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
16. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
17. Synovial sarcoma: identification of low and high risk groups.
Bergh P; Meis-Kindblom JM; Gherlinzoni F; Berlin O; Bacchini P; Bertoni F; Gunterberg B; Kindblom LG
Cancer; 1999 Jun; 85(12):2596-607. PubMed ID: 10375108
[TBL] [Abstract][Full Text] [Related]
18. Head and neck synovial sarcomas.
Pai S; Chinoy RF; Pradhan SA; D'Cruz AK; Kane SV; Yadav JN
J Surg Oncol; 1993 Oct; 54(2):82-6. PubMed ID: 8412164
[TBL] [Abstract][Full Text] [Related]
19. Synovial sarcoma. A clinicopathological study of 31 cases.
Santavirta S
Arch Orthop Trauma Surg; 1992; 111(3):155-9. PubMed ID: 1316772
[TBL] [Abstract][Full Text] [Related]
20. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.
Lewis JJ; Antonescu CR; Leung DH; Blumberg D; Healey JH; Woodruff JM; Brennan MF
J Clin Oncol; 2000 May; 18(10):2087-94. PubMed ID: 10811674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
